hypoglycemia (low blood sugar) and MRI for Type 1 Diabetes

Phase-Based Progress Estimates
University of Minnesota, Minneapolis, MNType 1 Diabetes+1 Morehypoglycemia (low blood sugar) and MRI - Other
18 - 65
All Sexes
What conditions do you have?

Study Summary

This trial is testing the effects of diabetes and high/low blood sugar and insulin on the brain. You were chosen as a possible participant because you are either healthy or have diabetes.

Eligible Conditions
  • Type 1 Diabetes
  • Healthy Subjects

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Baseline to 2 month

Baseline to 2 month
Change in Euglycemic GABA level in hypothalamus using MRI

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

type 1 diabetes
1 of 2
healthy controls
1 of 2

Experimental Treatment

Non-Treatment Group

40 Total Participants · 2 Treatment Groups

Primary Treatment: hypoglycemia (low blood sugar) and MRI · Has Placebo Group · N/A

type 1 diabetes
Experimental Group · 1 Intervention: hypoglycemia (low blood sugar) and MRI · Intervention Types: Other
healthy controls
PlaceboComparator Group · 1 Intervention: hypoglycemia (low blood sugar) and MRI · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 2 month

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,274 Previous Clinical Trials
1,488,446 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are a healthy person participating in the study as a control group.

Who else is applying?

What state do they live in?
What site did they apply to?
University of Minnesota100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%

How responsive is this trial?

Typically responds via
Phone Call100.0%
Most responsive sites:
  1. University of Minnesota: < 48 hours
Average response time
  • < 2 Days

Frequently Asked Questions

What is the participant limit for this experiment?

"Affirmative. According to clinicaltrials.gov, the research project that was initially published on October 31st 2019 is presently seeking participants. At this time, only 40 people are required for enrollment at 1 medical center with updates having been made as recently as February 9th 2022." - Anonymous Online Contributor

Unverified Answer

Does this study permit participation from individuals younger than fifty years of age?

"For eligibility, applicants must be aged 18 or older and below the age of 65." - Anonymous Online Contributor

Unverified Answer

Are individuals currently being recruited for this trial?

"Per clinicaltrials.gov, this experiment is seeking volunteers. It was initially listed on October 31st 2019 and modified most recently on February 9th 2022." - Anonymous Online Contributor

Unverified Answer

Is it possible for me to partake in this investigation?

"For this clinical trial, 40 individuals between the ages of 18-65 that have been diagnosed with type 1 diabetes mellitus are being enrolled. To be eligible for participation, patients must also demonstrate well-controlled blood sugar levels (HbA1c <7.5%) and meet additional healthy control criteria." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.